Glucotrack, Inc. Files 8-K
Ticker: GCTK · Form: 8-K · Filed: Oct 22, 2024 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financial-exhibits
TL;DR
Glucotrack filed an 8-K today, expect updates soon.
AI Summary
Glucotrack, Inc. filed an 8-K on October 22, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure or exhibits.
Why It Matters
This 8-K filing indicates Glucotrack, Inc. is making a regulatory disclosure and submitting financial exhibits, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- October 22, 2024 (date) — Date of earliest event reported
FAQ
What is the specific nature of the Regulation FD Disclosure?
The filing does not specify the details of the Regulation FD Disclosure.
What financial statements and exhibits are included in this filing?
The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
Has Glucotrack, Inc. undergone any recent name changes?
Yes, the company was formerly known as GlucoTrack, Inc. and prior to that, Integrity Applications, Inc., with name changes occurring on March 28, 2022, and December 3, 2010, respectively.
What is Glucotrack, Inc.'s principal executive office address?
The principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.
What is the SEC file number for Glucotrack, Inc.?
The SEC file number for Glucotrack, Inc. is 001-41141.
Filing Stats: 488 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-10-22 09:18:36
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 20KB
- 0001493152-24-041901.txt ( ) — 261KB
- gctk-20241022.xsd (EX-101.SCH) — 3KB
- gctk-20241022_lab.xml (EX-101.LAB) — 33KB
- gctk-20241022_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 22, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer